Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis

Medical Science Monitor

Volumn 8, Issue 3, 2002, Pages

  Wankiewicz, Anna ^a   Iwan Ziȩtek, Iza ^a   Kotchy, Maria ^a   Gwieździński, Zenon ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Dermatitis herpetiformis; Fibrinolysis

Indexed keywords

ALPHA 2 ANTIPLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; BULLOUS SKIN DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; DIAGNOSTIC VALUE; FEMALE; FIBRINOLYSIS; HORMONE ACTION; HUMAN; MALE; PLASMINOGEN ACTIVATION;

ADULT; AGED; ANTIPLASMIN; AUTOIMMUNE DISEASES; DERMATITIS HERPETIFORMIS; FEMALE; FIBRINOLYSIS; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PLASMINOGEN; PLASMINOGEN INACTIVATORS; SEX FACTORS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036199864     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Diseases associated with dermatitis herpetiformis
2. Risk factors of ischaemic heart disease in patients with dermatitis herpetifotmis
3. Factors regulating the process of fibrinolysis
4. The physiological aspects of fibrinolysis